Observational multicentric national longitudinal study evaluating Ibrance (palbociclib) in a real life setting conditions in patients 70 years old and older presenting a locally advanced or metastatic HR+/HER2- breast cancer (PalomAGE)

07/03/2018
16/12/2025
EU PAS number:
EUPAS23012
Study
Finalised
Documents
Study protocol
No information provided.
Study results
No information provided.
Study report
No information provided.
Publications
ENCePP Seal
Composition of steering group and observers
English (18.87 KB - PDF) View document